ATE370234T1 - Page-4, ein gage-ähnliches gen auf dem x- chromosom das von neoplastischer prostata, testis und uterus exprimiert wird, und dessen anwendungen - Google Patents

Page-4, ein gage-ähnliches gen auf dem x- chromosom das von neoplastischer prostata, testis und uterus exprimiert wird, und dessen anwendungen

Info

Publication number
ATE370234T1
ATE370234T1 AT99945389T AT99945389T ATE370234T1 AT E370234 T1 ATE370234 T1 AT E370234T1 AT 99945389 T AT99945389 T AT 99945389T AT 99945389 T AT99945389 T AT 99945389T AT E370234 T1 ATE370234 T1 AT E370234T1
Authority
AT
Austria
Prior art keywords
page
uterus
prostate
gene
gage
Prior art date
Application number
AT99945389T
Other languages
English (en)
Inventor
Ira Pastan
Ulrich Brinkmann
George Vasmatzis
Byungkook Lee
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE370234T1 publication Critical patent/ATE370234T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT99945389T 1998-09-01 1999-08-31 Page-4, ein gage-ähnliches gen auf dem x- chromosom das von neoplastischer prostata, testis und uterus exprimiert wird, und dessen anwendungen ATE370234T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9899398P 1998-09-01 1998-09-01

Publications (1)

Publication Number Publication Date
ATE370234T1 true ATE370234T1 (de) 2007-09-15

Family

ID=22271898

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99945389T ATE370234T1 (de) 1998-09-01 1999-08-31 Page-4, ein gage-ähnliches gen auf dem x- chromosom das von neoplastischer prostata, testis und uterus exprimiert wird, und dessen anwendungen

Country Status (8)

Country Link
US (2) US7399827B1 (de)
EP (1) EP1108023B1 (de)
JP (1) JP2003502273A (de)
AT (1) ATE370234T1 (de)
AU (1) AU766278B2 (de)
CA (1) CA2341642C (de)
DE (1) DE69936868T2 (de)
WO (1) WO2000012706A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2266772B (en) * 1992-04-30 1995-10-25 Pollution Control & Measuremen Detecting particles in a gas flow
US6902892B1 (en) 1998-10-19 2005-06-07 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
EP1605045A3 (de) * 2000-02-15 2006-03-01 Curagen Corporation Polypeptide und dafür kodierende Nukleinsäure
WO2001061009A2 (en) * 2000-02-15 2001-08-23 Curagen Corporation Polypeptides and nucleic acids encoding same
EP1179589A1 (de) * 2000-08-08 2002-02-13 F. Hoffmann-La Roche Ag MMX-1, Mitglied der Tumor/Testis-Antigenfamilie und Verfahren zur Bestimmung von metastatischer Fähigkeit eines Tumors
WO2004092213A1 (en) 2003-04-08 2004-10-28 The Government Of The United States Of America As Represented By The Secretary, Department Of Healthand Human Services Gene expressed in prostate cancer, methods and use thereof
DK1989224T3 (da) * 2006-02-24 2011-02-14 Us Gov Health & Human Serv Immunogene peptider og anvendelsesmetoder
WO2008106551A2 (en) 2007-02-28 2008-09-04 The Govt. Of The U.S.A. As Represented By The Secretary Of The Dept. Of Health & Human Serv. Brachyury polypeptides and methods for use
DE102010044283A1 (de) * 2010-09-03 2012-03-08 M04 Tech Ug (Haftungsbeschränkt) Vorrichtung und Verfahren zur Analyse biologischer Proben
US9402916B2 (en) 2011-03-17 2016-08-02 The University Of Birmingham Re-directed immunotherapy
ES2752190T3 (es) 2012-09-14 2020-04-03 Us Health Proteína Brachyury, vectores adenovirales que codifican proteína Brachyury y su uso
MY187178A (en) * 2015-02-18 2021-09-08 Hoffmann La Roche Immunoconjugates for specific induction of t cell cytotoxicity against a target cell

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5662907A (en) 1992-08-07 1997-09-02 Cytel Corporation Induction of anti-tumor cytotoxic T lymphocytes in humans using synthetic peptide epitopes
JP3908271B2 (ja) * 1993-03-05 2007-04-25 エピミューン，インコーポレイティド Ｈｌａ−ａ２．１結合ペプチドおよびそれらの使用
US5877016A (en) * 1994-03-18 1999-03-02 Genentech, Inc. Human trk receptors and neurotrophic factor inhibitors
DK0970206T3 (da) 1997-01-27 2008-10-13 Ludwig Inst Cancer Res Lage-1-tumorassocierede nukleinsyrer

Also Published As

Publication number Publication date
CA2341642C (en) 2011-05-24
AU766278B2 (en) 2003-10-16
AU5799399A (en) 2000-03-21
US20070248972A1 (en) 2007-10-25
JP2003502273A (ja) 2003-01-21
WO2000012706A1 (en) 2000-03-09
DE69936868D1 (de) 2007-09-27
EP1108023B1 (de) 2007-08-15
CA2341642A1 (en) 2000-03-09
US7399827B1 (en) 2008-07-15
DE69936868T2 (de) 2008-05-15
EP1108023A1 (de) 2001-06-20

Similar Documents

Publication Publication Date Title
DE69936868D1 (de) Page-4, ein gage-ähnliches gen auf dem x-chromosom das von neoplastischer prostata, testis und uterus exprimiert wird, und dessen anwendungen
Van den Eynde et al. T cell defined tumor antigens
ES2387685T3 (es) Péptido WT1 restringido por HLA-A*3303 y composición farmacéutica que comprende el mismo
DE69231245D1 (de) Veraendertes gen bei menschlichem colorektalem-krebs
CY1109463T1 (el) Πεπτιδια kdr και εμβολια που τα περιλαμβανουν
DE60134178D1 (de) Trp8 krebsmarker
HUP9801826A2 (hu) HER-2/neu-fehérje intracelluláris doménje, és alkalmazása malignitások megelőzésére és kezelésére
EP1315965A4 (de) Verfahren und zusammensetzungen für "targeting" in vitro
ES2205132T3 (es) Subunidad catalitica de la telomerasa humana.
NO20053999D0 (no) Survivin-avledede peptider og bruken av dem
ATE291614T1 (de) Diagnose und behandlung von zellproliferativen erkrankungen mit beteiligung von klonalen makrophagen
MXPA02011093A (es) Composiciones y metodos para el diagnostico, tratamiento y prevencion de canceres que responden a la hormona esteroidea.
ATE407206T1 (de) Methoden zu herstellung von genbanken
CY1110029T1 (el) Γονιδιο που εκφραζεται στον καρκινο του προστατη
ATE229073T1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
CY1108462T1 (el) Χρηση της αναστροζολης για τη θεραπευτικη αντιμετωπιση μετεμμηνοπαυσιακων γυναικων με καρκινο του μαστου σε πρωιμο σταδιο
CN109963585A (zh) 包括细胞穿透肽、多表位和tlr肽激动剂的用于治疗癌症的融合物
WO1999027098A3 (en) A-33 related antigens and their pharmacological uses
HUT64569A (en) A process for preparing polypeptide-type compounds usefules for medical treatment of the human body
HUP0300054A1 (hu) Daganatspecifikus állati fehérjék
CY1112202T1 (el) Υποδοχεας συζευγμενος προς g πρωτεϊνη θετικως ρυθμισμενος σε καρκινο προστατη και χρησεις αυτου
AR037343A1 (es) Uso de antagonistas del receptor de endotelina para la preparacion de un medicamento destinado al tratamiento de enfermedades tumorales
ES2959600T3 (es) Método para producir medicamentos para combatir tumores
CA2212563A1 (en) Process for obtaining medically active fractions from sea cucumbers
ES2174103T3 (es) Uso de las secuencias reguladoras de wap o mmtv para expresion dirigida de genes heterologos ligados en celulas mamarias humanas, con inclusion de celulas de carcinoma mamario humano.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties